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1. INTRODUCTION
Escherichia coli O157:H7 is an important food-borne, 
zoonotic pathogen that causes hemorrhagic colitis and 
hemolytic uremic syndrome (HUS) in humans (Bell, 
2002). It is the prototype of the enterohemorrhagic E. 
coli (EHEC) class, all of which produce Shiga toxin 
(Stx) and cause attaching–effacing (A/E) lesions (Law, 
2000). In the United States, ground beef is the most 
common vehicle associated with food-borne outbreaks 
of E. coli O157:H7 ([Caprioli et al., 2005] and [Bar-
low et al., 2006]). Cattle are an asymptomatic reser-
voir of this microorganism; their fecal material is an 
important source of food and water contamination, 
and means of spread to humans through direct con-
tact (Renter and Sargeant, 2002).
E. coli O157:H7 expresses an outer membrane pro-
tein known as intimin (Eae) and several type III se-
creted proteins that are involved in the induction of 
A/E lesions in the intestinal epithelium. Some of the 
more well-characterized type III secreted proteins in-
clude the translocated intimin receptor (Tir) and the 
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E. coli-secreted proteins [Esp] A and B (Hartland et 
al., 2000). Proteins involved in the induction of A/E le-
sions are encoded by genes on a chromosomal patho-
genicity island known as the locus of enterocyte ef-
facement (LEE) (Frankel et al., 1998). Tir, EspB and 
other LEE-encoded type III secreted effector proteins 
are delivered into the host cell through a transiently 
produced fi lamentous translocation tube (Nougayrede 
et al., 2003), which consists of an assembly of EspA 
subunits (Frankel et al., 1998). These effectors cause 
a series of cytoskeletal alterations resulting in efface-
ment of the microvilli and pedestal formation at the 
site of bacterial attachment (Roe et al., 2003). Tir, 
which has become integrated into the host cell mem-
brane, is bound to intimin, and this event mediates 
intimate attachment of the bacterium to the host cell 
(DeVinney et al., 1999).
Intimate attachment of bacteria to mucosal epithe-
lial cells signifi cantly enhances intestinal colonization 
in cattle and other species. The induction of A/E le-
sions in colonic and rectal (Baehler and Moxley, 2000) 
and ileal (Phillips et al., 2000) epithelial cells of adult 
cattle by E. coli O157:H7 was fi rst demonstrated using 
mucosal explants (in vitro organ cultures). Later, these 
lesions were demonstrated in vivo in adult cattle with 
the further identifi cation of the terminal rectum as a 
major site of colonization (Naylor et al., 2005). Fur-
ther conclusive evidence of the importance of A/E le-
sion formation in colonization has been based on stud-
ies with LEE gene deletion mutants. Deletion of eae or 
the LEE4 operon caused a signifi cant reduction in en-
teritis and bacterial fecal shedding in experimentally 
infected calves ([Dean-Nystrom et al., 1998] and [Nay-
lor et al., 2005]). Similarly, deletion of eae resulted in 
reduced colonization and fecal shedding in experimen-
tally infected yearling cattle (Cornick et al., 2002).
Human patients with HUS caused by E. coli O157:
H7 infection have robust serum antibody responses to 
Tir ([Li et al., 2000] and [Yoh et al., 2003]). Based on 
this observation, the hypothesis was raised that type 
III secreted proteins would be a suitable vaccine tar-
get for this pathogen in humans and cattle (Li et al., 
2000). Subsequent studies demonstrated that a vac-
cine prepared from culture supernatant materials en-
riched with LEE-encoded type III secreted proteins 
has signifi cant potential as a pre-harvest intervention 
strategy for E. coli O157:H7 in cattle (Potter et al., 
2004). Experimental challenge of calves with an E. 
coli O157:H7 strain containing a deletion of the LEE4 
operon also provided proof-of-concept for the utiliza-
tion of type III secreted proteins as a vaccine strategy 
(Naylor et al., 2005).
Some studies have not found vaccination to be ef-
fi cacious. One was a large-scale clinical trial in feed-
lot cattle which utilized type III secreted proteins as 
the vaccine antigen. In that study, the proteins were 
treated with formalin, which may have altered their 
immunogenicity (van Donkersgoed et al., 2005). In 
another study, young calves vaccinated with different 
EHEC antigens developed humoral and salivary IgA 
responses, but were not protected against intestinal 
colonization by E. coli O157:H7 following experimen-
tal challenge (van Diemen et al., 2007).
Although vaccination of cattle is being actively 
pursued as an intervention strategy for E. coli O157:
H7, little is known about the bovine immune re-
sponses to important bacterial colonization factors re-
sulting from infection. Many of these factors could po-
tentially serve as immunogens, but no information is 
available about the effects of infection in this regard, 
which may serve as a priming exposure to the respec-
tive antigen. Further, very few studies have been con-
ducted in slaughter-age (adult yearling) cattle, which 
are the most relevant model, since these animals are 
the main source of ground beef for human consump-
tion. The primary objective of this study was to deter-
mine whether adult cattle develop signifi cant serum 
and fecal antibody responses to LEE-encoded proteins 
in response to infection with E. coli O157:H7.
2. MATERIALS AND METHODS
2.1. Experimental animals
Thirty healthy crossbred yearling beef cattle (~16 
months old, mean weight, 447.7 ± 86.0 kg) were ob-
tained from the University of Nebraska-Lincoln 
(UNL) herd at Ithaca, NE. Prior to beginning the 
study, the cattle were prophylactically treated with 
topical ivermectin pour-on (0.5 mg/kg BW; ProMec-
tin B, Vedco, St. Joseph, MO) and oral sulfametha-
zine boluses (350 mg/kg BW; Sustain III, Bimeda, 
Inc., Le Sueur, MN). The week immediately prior to 
inclusion into the study, each animal tested nega-
tive for coccidia and nematodes by fecal fl otation tech-
nique and ectoparasites by clinical examination. Each 
animal also was negative for Salmonella spp. and E. 
coli O157:H7 in three successive fecal cultures over a 
1-week period, using standard enrichment and plat-
ing methods ([Smith et al., 2001] and [Smith et al., 
2005]), and negative for bovine viral diarrhea virus 
by antigen capture ELISA conducted on sera. Follow-
ing the health screen, the cattle (n = 30) were tested 
by indirect ELISA for pre-existing serum IgG and 
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IgA antibodies to E. coli O157:H7 intimin, Tir, EspA, 
EspB and O157 LPS, as described below. Thereafter, 
six of these animals, chosen at random, were trans-
ported to and individually housed in biosafety level 
(BL)-2 containment rooms. One week prior to use, 
BL-2 isolation rooms were disinfected by fumigation 
with paraformaldehyde. Cattle were fed once daily 
with a nutritionally balanced ration without antibi-
otics (UNL Beef Feed 51786AAA, Consolidated Nu-
trition, Omaha, NE) and water was available ad li-
bitum. Cattle were acclimated to the rooms and diet 
prior to inoculation.
2.2. BL-2 animal isolation rooms
BL-2 animal isolation rooms had individual fl oor 
drains, and fl oors and walls were washed once daily 
with water via a high pressure sprayer to minimize 
repeated challenge from bacteria shed through each 
animal’s own feces. Cross-contamination was pre-
vented by housing one animal per room, and by hav-
ing animal caretakers and research personnel change 
personal protective equipment (except respirators) 
and clothing between rooms. Animal waste was au-
toclaved in a sewage sterilization plant prior to dis-
charge in the municipal sewage system.
2.3. Experimental design
Six healthy yearling beef cattle, individually housed 
in BL-2 isolation rooms, were orally inoculated once 
in the feed with 1 × 109 CFU of E. coli O157:H7 (wild-
type strain 86-24), and each animal was observed 
to consume the entire feed sample. EHEC O157:H7 
strain 86-24 is Stx2+, and was originally isolated from 
a human patient with bloody diarrhea (Griffi n et al., 
1988). After inoculation, cattle were examined once 
daily for clinical signs for the duration of the study. 
Animal experiments were approved by the UNL In-
stitutional Animal Care and Use Committee, and the 
UNL Institutional Biosafety Committee.
2.4. Sample collection and examination
Samples were collected daily from the centers of 
fresh fecal pats on the fl oor for 14 days post-challenge 
(DPC), and on alternate days for 28 days thereafter 
to quantify levels of fecal shedding of the inoculum 
strain. Previous studies have shown the usefulness 
of copro-antibody quantifi cation for the assessment 
of intestinal immunoglobulins in calves (Heckert et 
al., 1991) and other ruminant species (Rehbinder and 
Hau, 2006). Therefore, fecal samples from the rectum 
were collected to test for intestinal antibodies, and se-
rum samples from the jugular vein were obtained to 
assess the humoral response on 0, 14, 28 and 42 DPC. 
Immediately after their collection, serum samples 
were stored at −20 °C; whereas fecal samples were 
suspended 1:5 (w/v) in sodium acetate buffer (pH 4.5, 
10 mM) containing 0.1% (w/v) soybean trypsin inhib-
itor, 5 mM EDTA, 80 μg/ml of gentamicin, 10 IU/ml 
penicillin, and 10 μg/ml of streptomycin (Dréau et al., 
1995). The mixture was centrifuged once at 2500 × g 
for 20 min to sediment larger particles and once at 
15,000 × g for 30 min. Finally, the supernatant was 
collected and stored at −20 °C until the analysis could 
be performed.
2.5. Fecal shedding
Fecal samples were obtained via fresh pats on the 
fl oor and immediately processed. Each sample was 
quantifi ed by direct plating (DP) on SMAC-CT (sor-
bitol-MacConkey plates containing 0.5 μg/ml cefi xime 
and 2.5 μg/ml potassium tellurite) plates and cultured 
in enrichment broth (GN-VCC = GN broth containing 
8 μg/ml vancomycin, 0.05 μg/ml cefi xime and 10 μg/
ml cefsulodin) followed by plating on SMAC-CT to de-
tect levels of shedding that were undetectable by DP. 
For enrichment (E) culture, 10 g of feces were incu-
bated in 90 ml of GN-VCC for 6 h at 37 °C. One mil-
lilitre of these cultures was subjected to O157 immu-
nomagnetic separation (IMS, Dynal) and 50 μl of the 
mixture were spread on SMAC-CT plates. Sorbitol-
nonfermenting colonies were subcultured on MacCo-
nkey and Fluorocult (E. Merck) agars. Colonies that 
fermented lactose but not sorbitol, and lacked β-gluc-
uronidase activity [non-fl uorescent on Fluorocult, 
which contains 4-methylumbelliferyl-β-d glucuronide 
(MUG)], were further tested for reactions in triple 
sugar iron, indole and methyl red-Voges-Proskauer 
media. Indole-positive isolates were subcultured onto 
blood agar and tested for E. coli O157 and H7 anti-
gens by latex agglutination test (Remel RIM® E. coli 
O157:H7 Latex Test). Isolates giving the expected re-
actions in the aforementioned tests were thus identi-
fi ed as E. coli O157:H7.
2.6. Antibody response
Isotype-specifi c (IgA and IgG) fecal and serum anti-
body titers were determined by an indirect ELISA us-
ing a modifi cation of the procedures previously de-
scribed by Li et al. (2000). E. coli BL21, a λDE3 lysogen 
strain containing a pET28 expression vector, kindly 
provided by Dr. B. Brett Finlay (University of Brit-
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ish Columbia), was the source of E. coli O157:H7 pro-
tein antigens. This strain expresses histidine-tagged 
eae, tir-CesT, espB or espA genes. CesT is the chaper-
one protein for Tir, which is required for Tir protein 
stability (Abe et al., 1999). The region of the eae gene 
cloned into the recombinant intimin construct encodes 
the 280-carboxyl-terminal amino acids, specifi c for the 
γ-intimin subtype. Purifi ed proteins were obtained us-
ing commercially available Ni2+ affi nity columns (No-
vagen His-Bind Kit, EMD Biosciences-Merck). The 
source of E. coli O157 LPS was E. coli O157:H7 strain 
86-24, obtained by phenol–water extraction and pu-
rifi ed by standard methods (Jann, 1985). Individual 
wells of microtiter plates were coated with 100 μl of 
Tir (100 ng), intimin (180 ng), EspA (160 ng), EspB 
(240 ng) (Li et al., 2000), or O157 LPS (150 ng) in a 
0.1 M carbonate buffer (pH 9.6), and incubated over-
night at 4 °C. After two washes with PBS, wells were 
blocked with 1% BSA, heat-treated at 60 °C, in car-
bonate buffer. Serum samples were serial twofold di-
luted in PBS and tested at a starting dilution of 1:100 
for IgG or 1:20 for IgA. Fecal samples were also seri-
ally diluted in PBS, but the initial dilution tested for 
both IgG and IgA antibodies was the undiluted pro-
cessed sample (1:5 in sodium acetate buffer). Plates 
were incubated for 2 h at 37 °C, washed and blocked, 
as previously described (Li et al., 2000). One hundred 
microlitre of a 1:10,000 PBS dilution of horseradish 
peroxidase-conjugated goat anti-bovine IgG (H + L, 
affi nity purifi ed; Jackson Immunoresearch Labora-
tories) or 1:5000 PBS dilution of horseradish perox-
idase-conjugated rabbit anti-bovine IgA (Bethyl Lab-
oratories, Inc.) was added to each well. Plates were 
incubated for 1 h at 37 °C, and washed three times 
with PBS. Orthophenylenediamine plus hydrogen 
peroxide was used as the substrate for the reaction. 
ELISAs were read at a wavelength of 490 nm. Three 
duplicate determinations were performed for each 
sample. The antibody titer was the highest dilution 
having an absorbance (mean − 2 ≥ S.D.) greater than 
the negative control (mean + S.D.), which included all 
reagents except the serum.
2.7. Statistical analysis
The level and length of fecal shedding were deter-
mined. The mean magnitude and duration of fecal 
shedding were estimated for the fi rst 14 DPC. Af-
ter 14 DPC, shedding was evaluated on alternate 
days for 28 days. Two means, each calculated from 
seven observation points over a 14-day sampling pe-
riod were determined. The mean magnitude of fecal 
shedding was the geometric mean (GM) expressed as 
log10 CFU/g (wet weight) of feces. The mean duration 
of fecal shedding based on DP or E-IMS, expressed as 
the percent of days in which E. coli O157:H7 was de-
tected was determined. GM antibody titers were calcu-
lated from the highest dilution of each serum sample 
in which a detectable immune response was deter-
mined ([Li et al., 2000] and [Potter et al., 2004]). To 
determine the statistical distribution of the antibody 
titers, a normality test was performed by the UNI-
VARIATE procedure of SAS (1999), using the Shap-
iro–Wilks W statistic. Because antibody titers were 
not normally distributed, they were analyzed by the 
non-parametric Kruskal–Wallis test, followed by the 
Tukey–Kramer test for comparison of means (Dowdy 
and Wearden, 1991) by SAS (1999). The association 
between fecal shedding and serum IgG responses 
(pre-existing or post-challenge titers) was assessed 
by Spearman’s correlation analysis (Proc CORR, SAS, 
1999). A signifi cant difference was declared to exist 
when P ≤ 0.05. Least squares means (LSM) and the 
S.E.M. are reported, unless otherwise stated.
3. RESULTS
3.1. Animal health
All animals were healthy throughout the experiment, 
including the time period after inoculation with E. 
coli O157:H7. Although cattle actively shed E. coli 
O157:H7, none developed anorexia or diarrhea, and 
all maintained or gained weight during the 42-day ex-
perimental period.
3.2. Pre-inoculation serum IgG and IgA 
antibody titers
Pre-inoculation serum antibody titers to O157 LPS 
and E. coli O157:H7 intimin, Tir, EspB and EspA 
were determined by indirect ELISA with individual 
serum samples taken from 30 healthy adult beef cat-
tle (Figure 1). All animals were IgG-seropositive for 
all fi ve antigens, with GM IgG titers to EspB and 
O157 LPS antigens signifi cantly higher (P < 0.05) 
than those detected for Tir, intimin and EspA. Cat-
tle were also seropositive for IgA antibodies to each 
antigen; however, as expected, the titers were much 
lower than those detected for serum IgG. The serum 
IgA titer to EspB was signifi cantly higher (P < 0.05) 
than that to all other antigens. Although the serum 
IgA titer to Tir was signifi cantly lower (P < 0.05) than 
that to EspA, the former was not signifi cantly differ-
ent (P > 0.05) from IgA titers to O157 LPS or intimin. 
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3.3. Magnitude and duration of fecal shedding 
after experimental inoculation with E. coli 
O157:H7
There was a wide variation in the magnitude 
(log10 CFU/g) and duration (percent of days positive) 
of fecal shedding among animals. The challenge or-
ganism was shed in the feces at relatively high levels 
(GM, 412 CFU/g) over the fi rst 14 DPC. From 15 to 
42 DPC the magnitude of shedding decreased ~98% 
compared to 1–14 DPC; however, cattle continued to 
shed the microorganism at low levels, indicating that 
they were colonized, and that pre-existing serum anti-
bodies to O157 LPS and A/E proteins did not prevent 
cattle from intestinal colonization by E. coli O157:H7.
Based on the DP and E-IMS procedures, the per-
cent of positive days (mean ± S.D.) of detection of 
E. coli O157:H7 in feces, as a measure of duration 
of shedding for the fi rst 14 DPC, was 57 ± 23% and 
81 ± 34%, respectively. Thus, as indicated by the du-
ration of fecal shedding, E-IMS procedure was consis-
tently more sensitive for the recovery of E. coli O157:
H7 from feces than DP culture. As determined by DP, 
fecal shedding of E. coli O157:H7, on the average, be-
came undetectable at 24 DPC (range of 8–42 days), 
whereas by E-IMS procedure a complete decline in fe-
cal shedding was established at an average of 27 DPC 
(range of 8–42 days).
3.4. Serum and fecal antibody titers following 
experimental inoculation with E. coli O157:H7
Serum and fecal antibody titers to O157 LPS and E. 
coli O157:H7 intimin, EspA, EspB and Tir were deter-
mined at 0, 14, 28 and 42 DPC, and compared with the 
magnitude of fecal shedding in orally inoculated cattle. 
There was no relationship between pre-existing titer to 
any antigen and the level of shedding after inoculation 
(P > 0.4; Figure 2). However, infection resulted in an 
increase in the serum IgG titers to LEE-encoded pro-
teins above that of the pre-inoculation levels (Figure 3). 
Coincident with the highest level of fecal shedding at 
14 DPC, the GM titers to intimin, Tir and EspB were 
signifi cantly increased (P < 0.05), whereas a signifi cant 
increase (P < 0.05) in the anti-EspA serum response 
was detected later, at 28 DPC. At 14 DPC, cattle also 
had a 1.7-fold increase in their serum IgG titers to 
O157 LPS; however, this difference was not signifi cant 
(P > 0.05). By 42 DPC, the titers to all antigens, except 
EspB, were on the decline following the low level of fe-
cal shedding. The serum IgG titers to Tir, intimin and 
O157 LPS (r = 0.98, P < 0.05), but not EspA or EspB 
were highly correlated with the level of fecal shedding. 
Although not statistically signifi cant (P > 0.05), serum 
IgA titers to O157 LPS increased, whereas those to in-
timin, EspB and Tir decreased by 14 DPC (Figure 4). 
Pre- and post-inoculation fecal IgG and IgA antibodies 
to LEE-encoded proteins and O157 LPS were not de-
tected (<1:5). 
4. DISCUSSION
The major fi nding of this study was that adult cattle 
developed a signifi cant serum IgG antibody response 
to E. coli O157:H7 LEE-encoded proteins (Tir, EspA, 
EspB and Tir) following infection. At the inoculum 
Figure 1. Pre-existing serum IgG and IgA titers to O157 LPS and locus of enterocyte effacement (A/E) proteins in adult cat-
tle. LSM and S.E.M. are presented. Bars (IgG) or dashes (IgA) with the same letters are not signifi cantly different (P > 0.05), 
n = 30. Samples were tested at a starting dilution of 1:100 for IgG or 1:20 for IgA followed by serial twofold dilutions thereaf-
ter. Serological titers are expressed as median values of the highest positive dilution of sera. 
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level we used (1 × 109 CFU), we found that the serum 
IgG responses of cattle to O157 LPS, intimin, EspA, 
and Tir were short-lived, whereas that to EspB was 
greater and more prolonged. It is possible that the re-
sponses could have been higher and more pronounced 
with a higher inoculum level, since Johnson et al. 
(1996) reported that the serum anti-O157 antibody ti-
ters were sustained in adult cattle following an inoc-
ulation with 1 × 1010 CFU (Cray and Moon, 1995). To 
our knowledge, this is the fi rst study to report anti-
body responses to LEE-encoded proteins in cattle in 
response to experimental infection. It is of further im-
portance that the study was conducted in adult cattle, 
which are the major source of ground beef.
We inoculated cattle with a level of E. coli O157:
H7 thought to be within the range of a likely natu-
ral challenge dose ([Besser et al., 1997], [Besser et al., 
2001] and [Sanderson et al., 1999]). We housed the 
cattle individually in BL-2 isolation rooms to mini-
mize repeated exposure and prevent cross-contamina-
tion from other cattle (Besser et al., 2001), which al-
lowed us to more accurately ascertain the response to 
a known inoculum level. This approach has an advan-
tage over studying the duration of shedding in natu-
ral conditions, since it is diffi cult in the latter situa-
tion to determine the actual inoculum level.
The inoculum dose used in our study was suf-
fi cient to induce colonization, as evidenced by the 
length of fecal shedding, which ranged from 8 to 42 
days (mean, 24), and the length of shedding was com-
parable to that detected in natural infections ([Besser 
et al., 1997] and [Khaitsa et al., 2003]). Besser et al. 
(1997) reported that the duration of detected fecal ex-
cretion of E. coli O157:H7 by naturally infected cat-
Figure 2. Infl uence of pre-existing serum IgG titers to O157 LPS and locus of enterocyte effacement (A/E) proteins on Esch-
erichia coli O157:H7 fecal shedding in orally inoculated adult cattle (n = 6). Serological titers are the highest positive dilu-
tion of sera. Fecal shedding is the mean of 14 days. The correlation between these two variables was not statistically signif-
icant (P > 0.4). 
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tle was <1 month in most cattle tested. Khaitsa et al. 
(2003) found that the duration of fecal shedding in 
feedlot cattle ranged from 1 to 4.5 weeks, and peaked 
during the epidemic phase, which corresponds to 
times of higher challenge levels.
In our study, since all cattle tested had pre-exist-
ing antibodies that had resulted from natural expo-
sure and they shed for 8–42 days after inoculation, 
we interpret that those responses were insuffi cient 
for complete protection. It is possible there was some 
effect on reduction of shedding; however, we did not 
fi nd any signifi cant relationship between pre-ex-
isting titer to any antigen and shedding. Our group 
and other researchers have found that young calves 
([Naylor et al., 2007] and [Sanderson et al., 1999]) 
and adult cattle ([Cray and Moon, 1995] and [Khaitsa 
et al., 2003]) shed less following repeated experimen-
tal inoculations, and this suggests that protective im-
mune responses do occur following infection. How-
ever, these responses are not completely protective, 
as evidenced by repeated infections in natural condi-
tions, and the fi nding that the duration of fecal shed-
ding in these conditions does not differ signifi cantly 
between the fi rst and second infections or fi rst and 
third infections (Khaitsa et al., 2003). Other investi-
gators have reported that serum anti-O157 responses 
were not correlated with elimination of infection or 
protection against reinfection with the same strain; 
however, they did not address the responses to anti-
gens that have been shown to be important for intes-
tinal colonization ([Johnson et al., 1996] and [Wray et 
al., 2000]).
The predominance of IgG over IgA antibodies 
found in this experiment is consistent with the con-
centrations of these immunoglobulin classes in se-
rum of adult cattle ([Mach and Pahud, 1971] and 
[Lascelles et al., 1986]). Although cattle are known to 
mount a signifi cant serum IgG titer to O157 LPS in 
response to infection with E. coli O157:H7 ([Johnson 
et al., 1996] and [Wray et al., 2000]), we cannot rule 
out the possibility of serologic cross-reactivity with 
certain other Gram-negative bacteria as a contribut-
ing factor for the pre-existing anti-O157 LPS IgG ti-
ters detected in this study ([Chart and Jenkins, 1999], 
[Laegreid et al., 1998] and [Nielsen et al., 2004]).
A recent study demonstrated that 6–8-week-old 
calves initially inoculated with an Stx− strain but not 
Stx2+ E. coli O157:H7 strain 86-24 developed statis-
tically signifi cant lymphoproliferative responses to 
heat-killed Stx2+ E. coli O157:H7 (Hoffman et al., 
2006). In the same study, all calves inoculated with 
E. coli O157:H7, regardless of Stx production by the 
respective strain, developed antibodies to O157 LPS. 
The authors hypothesized that Stxs are immunosup-
pressive and play a role in promoting STEC coloniza-
tion in the bovine host, despite the fact that cattle de-
velop humoral immune responses during the course 
of infection. Although cattle in the present study were 
Figure 3. Fecal shedding (□) (log10 colony-forming units/g) vs. serological IgG immune response to intimin, EspA, EspB and 
Tir (–) from yearling cattle (n = 6) orally inoculated with E. coli O157:H7 (Wild type 86-24 strain). At day 0 the pre-existing, 
fi eld-induced IgG titers are indicated. Serum samples were tested at a starting dilution of 1:100 followed by serial twofold 
dilutions thereafter. For each immune response, different letters across the X-axis indicate statistical difference (P < 0.05) 
among time points (days of bleeding: 0, 14, 28 and 42). LSM and S.E.M. are presented. Serological titers are expressed as 
median values of the highest positive dilution of sera. 
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inoculated with the same Stx2+ strain (86-24), we did 
not address their lymphoproliferative responses.
Overall, we detected a highly signifi cant, positive 
association between the pattern of fecal shedding and 
the serum IgG response to Tir, intimin or O157 LPS. 
Thus, such high positive correlation (r = 0.98) may ex-
plain the failure of these antigens to induce a long-
lasting serological IgG response following oral inoc-
ulation of cattle. In contrast to the serological IgG 
titers, the serum IgA titers to Tir, intimin and EspB 
decreased (P > 0.05) after oral challenge. Wray et al. 
(2000) found that serum IgM but not IgG antibody 
titers to O157 LPS in calves decreased after experi-
mental infection. These authors did not study the an-
tibody responses to other antigens, nor those of the 
IgA class. However, a very recent publication has re-
ported that young calves developed serum antibody 
responses of the IgG and IgA class to O157 and H7, 
and the IgA but not IgG titers decreased after colo-
nization following a repeat challenge (Naylor et al., 
2007). Interestingly, in our study, the IgA titers de-
creased only to factors having a known (Eae, Tir) 
or highly probable function in colonization (EspB), 
whereas those to O157 increased. Hence, as initially 
proposed by Wray et al. (2000) and extended by the 
fi ndings of this study and the recent one by Naylor 
et al. (2007), the decrease in serum IgM and IgA ti-
ters soon after challenge may be evidence of their con-
sumption in response to challenge, through binding to 
E. coli O157:H7 and its secreted products.
Mucosal antibodies to various antigens can be de-
tected in the feces of ruminants ([Heckert et al., 1991] 
and [Rehbinder and Hau, 2006]), rats (Hau et al., 2001) 
and humans (Vetvik et al., 1998). Digestive and bacte-
rial proteases can reduce the rate of recovery of anti-
bodies in the feces ([Grewal et al., 2000] and [Vetvik 
et al., 1998]). However, in the present study, copro-an-
tibodies against E. coli O157:H7 antigens were unde-
tectable despite immediate processing and freezer stor-
age of fecal samples, which were attempts to minimize 
proteolytic degradation. The lack of detection of copro-
antibodies in our study is similar to the results of Con-
lan et al. (1999), who reported a very sporadic detection 
of anti-O157 LPS fecal antibodies in mice orally chal-
lenged with E. coli O157:H7. In human patients with 
enteric disease, the rates of recovery of copro-antibod-
ies are signifi cantly higher in those with active gut in-
fl ammation (Ferguson et al., 1995).
In summary, this study has demonstrated that 
adult cattle respond serologically to E. coli O157:H7 
LEE-encoded type III secreted proteins and intimin 
as a result of infection. In general, protective muco-
sal immune responses are most effectively induced 
by mucosal immunization ([Dougan et al., 2000] and 
[Neutra and Kozlowski, 2006]), but very little infor-
mation is currently available concerning the bovine 
mucosal immune responses to E. coli O157:H7. More 
studies are needed in this regard in order to develop 
effective preventive and control strategies for E. coli 
O157:H7 in cattle. 
Figure 4. Fecal shedding (□) (log10 colony-forming units/g) vs. serological IgA immune response to O157 LPS and locus of 
enterocyte effacement proteins (–) from yearling adult cattle (n = 6) orally inoculated with E. coli O157:H7 (Wild type 86-24 
strain). Data of shedding are the same as those presented in Figure 3. At day 0 the pre-existing, fi eld-induced IgA titers are 
indicated. Serum samples were tested at a 1:20 starting dilution followed by serial twofold dilutions. Statistical differences 
were not found among time points (days of bleeding: 0, 14, 28 and 42) for any antigen. LSM and S.E.M. are presented. Sero-
logical titers are expressed as median values of the highest positive dilution of sera. 
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